Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

587 Articles

Trey Thoelcke | May 5, 2016 at 7:35 AM EDT

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an…

Chris Lange | Apr 28, 2016 at 9:10 AM EDT

Why AbbVie Earnings Failed to Impress Investors

AbbVie reported its first-quarter financial results and guidance before the markets opened on Thursday.

Chris Lange | Apr 27, 2016 at 9:15 AM EDT

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Sam Stebbins | Apr 26, 2016 at 6:57 AM EDT

The World’s 15 Top Selling Drugs

Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also…

Lee Jackson | Apr 20, 2016 at 8:25 AM EDT

2 Cheap Pharmaceuticals Highlight Jefferies Franchise Picks Dividend Stocks to Buy

These four Jefferies Franchise Picks are rated Buy and pay the highest dividends. They make good sense for investors now.

Chris Lange | Apr 12, 2016 at 9:50 AM EDT

Short Sellers Become More Selective in Major Pharma

The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Apr 4, 2016 at 8:35 AM EDT

4 Jefferies Franchise Picks With Big Dividends Are Solid Q2 Buys

Now all investor eyes turn to first-quarter earnings results. With interest rates still very low, investors looking to add capital…

Lee Jackson | Mar 30, 2016 at 11:05 AM EDT

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the…

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

Chris Lange | Mar 10, 2016 at 8:40 AM EST

Major Pharma Short Interest Takes a Small Step Back

The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Mar 9, 2016 at 10:10 AM EST

Large Cap Blue Chips Dominate Jefferies Top Value Stocks to Buy

In a recent research report, Jefferiesfocused on some large cap stocks that are still trading way below their 52-week highs.

Jon C. Ogg | Mar 7, 2016 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Enbridge, Micron, Sun Life, Starbucks, Stratasys, Wynn and Many More

The top analyst upgrades, downgrades and initiations seen from Monday, March 7, include Enbridge, Micron Technology, Sun Life Financial, Starbucks,…

Jon C. Ogg | Feb 26, 2016 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: American Water, Autodesk, Kraft Heinz, Palo Alto, Toyota, Vipshop and More

The top analyst upgrades, downgrades and initiations seen from Friday, February 26, include American Water Works, Autodesk, Kraft Heinz, Palo…

Chris Lange | Feb 25, 2016 at 8:10 AM EST

Short Sellers Increase Bets in Major Pharma

The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Lee Jackson | Feb 24, 2016 at 9:50 AM EST

Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks

These stocks make good sense for long-term patient investors that have a growth and income total return bias in their…

1 … 29 30 31 32 33 … 40

AbbVie : ABBV

All AbbVie Articles

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

Why AbbVie Earnings Failed to Impress Investors

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

The World’s 15 Top Selling Drugs

2 Cheap Pharmaceuticals Highlight Jefferies Franchise Picks Dividend Stocks to Buy

Short Sellers Become More Selective in Major Pharma

4 Jefferies Franchise Picks With Big Dividends Are Solid Q2 Buys

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Jefferies Top Drug Stocks for the Rest of 2016

Major Pharma Short Interest Takes a Small Step Back

Large Cap Blue Chips Dominate Jefferies Top Value Stocks to Buy

Top Analyst Upgrades and Downgrades: Enbridge, Micron, Sun Life, Starbucks, Stratasys, Wynn and Many More

Top Analyst Upgrades and Downgrades: American Water, Autodesk, Kraft Heinz, Palo Alto, Toyota, Vipshop and More

Short Sellers Increase Bets in Major Pharma

Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

3 Stocks With a Yield Over 6% For Passive Income Investors

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

A $2.5 Million 401(k) at 73 Can Still Cost You Six Figures Without These 3 Moves

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

AbbVie : ABBV

All AbbVie Articles

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

Why AbbVie Earnings Failed to Impress Investors

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

The World’s 15 Top Selling Drugs

2 Cheap Pharmaceuticals Highlight Jefferies Franchise Picks Dividend Stocks to Buy

Short Sellers Become More Selective in Major Pharma

4 Jefferies Franchise Picks With Big Dividends Are Solid Q2 Buys

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Jefferies Top Drug Stocks for the Rest of 2016

Major Pharma Short Interest Takes a Small Step Back

Large Cap Blue Chips Dominate Jefferies Top Value Stocks to Buy

Top Analyst Upgrades and Downgrades: Enbridge, Micron, Sun Life, Starbucks, Stratasys, Wynn and Many More

Top Analyst Upgrades and Downgrades: American Water, Autodesk, Kraft Heinz, Palo Alto, Toyota, Vipshop and More

Short Sellers Increase Bets in Major Pharma

Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

3 Stocks With a Yield Over 6% For Passive Income Investors

Featured Reads

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

A $2.5 Million 401(k) at 73 Can Still Cost You Six Figures Without These 3 Moves